MedTech Acquisition Corporation (MTAC)

NASDAQ: MTAC · IEX Real-Time Price · USD
10.19
-0.09 (-0.88%)
Mar 28, 2023, 4:00 PM EDT - Market closed
Market Cap 83.59M
Revenue (ttm) n/a
Net Income (ttm) 5.54M
Shares Out 8.20M
EPS (ttm) 0.19
PE Ratio 53.63
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 250
Open 10.19
Previous Close 10.28
Day's Range 10.19 - 10.20
52-Week Range 9.78 - 10.68
Beta -0.03
Analysts n/a
Price Target n/a
Earnings Date n/a

About MTAC

MedTech Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the healthcare sector in the United States.. The company was incorporated in 2020 and is based in Greenwich, Connecticut. [Read more]

Industry Shell Companies
Sector Financials
IPO Date Dec 18, 2020
Country United States
Stock Exchange NASDAQ
Ticker Symbol MTAC
Full Company Profile

Financial Performance

Financial Statements

News

TriSalus Life Sciences Appoints James Alecxih to Lead Device Technology Business

DENVER & CHICAGO--(BUSINESS WIRE)--TriSalus Life Sciences®, Inc. (“TriSalus” or the “Company”), an oncology company in the process of going public through a business combination transaction (the “Busi...

1 month ago - Business Wire

TriSalus Life Sciences Highlights Pressure-Enabled Regional Immuno-Oncology™ (PERIO™) Clinical Trial Progress and Pre-clinical Research Developments

DENVER & CHICAGO--(BUSINESS WIRE)--TriSalus Life Sciences®, Inc. (“TriSalus” or the “company”), an oncology company in the process of going public through a business combination transaction (the “Bu...

3 months ago - Business Wire

MedTech Acquisition Corporation Announces Adjournment of its Special Meeting in lieu of an Annual Meeting of Stockholders

The Company recommends all of its stockholders to vote FOR the Extension Amendment at the upcoming Special Meeting.

4 months ago - GlobeNewsWire

TriSalus Life Sciences Provides Updates on Pressure-Enabled Regional Immuno-Oncology™ (PERIO™) 01 and 02 Clinical Studies

TriSalus Life Sciences®, Inc. (“TriSalus”) (the “Company”), an oncology therapeutics company in the process of going public through a business combination transaction (the “Business Combination”) with...

4 months ago - Business Wire

TriSalus Life Sciences to Become Publicly Traded Through Merger With MedTech Acquisition Corporation

DENVER & FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--TriSalus Life Sciences® (the “Company” or “TriSalus”), a privately held oncology therapeutics company integrating immunotherapy with disruptive deliv...

4 months ago - Business Wire

MedTech Acquisition Corporation and Memic Innovative Surgery Ltd. Mutually Agree to Terminate Business Combination

TEL AVIV, Israel and FORT LAUDERDALE, Fla., March 10, 2022 (GLOBE NEWSWIRE) -- MedTech Acquisition Corporation (Nasdaq: MTAC) (“MedTech”), a publicly traded special purpose acquisition company (SPAC) ...

1 year ago - GlobeNewsWire

Memic Announces Adoption of Hominis® Surgical System at Three Leading U.S. Hospitals in Q4 2021

TEL AVIV, Israel and FORT LAUDERDALE, Fla., Jan. 6, 2022 /PRNewswire/ -- Memic Innovative Surgery Ltd.

1 year ago - PRNewsWire

Memic Announces Robert L. Ryan and Sandra Morgan to Join Board of Directors Upon Closing of Business Combination with MedTech Acquisition Corporation

TEL AVIV, Israel and FORT LAUDERDALE, Fla., Sept. 9, 2021 /PRNewswire/ -- Memic Innovative Surgery Ltd.

1 year ago - PRNewsWire

Peregrine Ventures Portfolio Company Memic Announces $1B Valuation SPAC deal

OR YEHUDA, Israel, Aug. 19, 2021 /PRNewswire/ -- Peregrine Ventures portfolio company Memic Innovative Surgery Ltd. has entered into a definitive agreement for a business combination with MedTech Acqu...

1 year ago - PRNewsWire

Memic Going Public Via SPAC: What Investors Should Know About This Medical Device Company

A SPAC led by the founder of Memic Innovative Surgery and several experienced medical device company executives has announced its merger partner.  The SPAC Deal: Memic Innovative Surgery announced a S...

1 year ago - Benzinga

Memic Innovative Surgery Ltd. and MedTech Acquisition Corporation Announce Proposed Business Combination

TEL AVIV, Israel and FORT LAUDERDALE, Fla., Aug. 13, 2021 /PRNewswire/ -- Memic Innovative Surgery Ltd.

1 year ago - PRNewsWire

MedTech Acquisition Corporation Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

New York, NY, June 02, 2021 (GLOBE NEWSWIRE) -- MedTech Acquisition Corporation (Nasdaq: MTACU) (the “Company”) today announced that it has received a notice (“Notice”) from the Listing Qualifications...

1 year ago - GlobeNewsWire

MedTech Acquisition Corporation Announces Separate Trading of its Class A Common Stock and Warrants, Commencing February 8, 2021

New York, NY, Feb. 05, 2021 (GLOBE NEWSWIRE) -- MedTech Acquisition Corporation (Nasdaq:MTACU) (the “Company”) announced today that, commencing February 8, 2021, holders of the 25,000,000 units sold i...

2 years ago - GlobeNewsWire

MedTech Acquisition Corporation Announces Closing of Upsized $250,000,000 Initial Public Offering

New York, NY, Dec. 22, 2020 (GLOBE NEWSWIRE) -- MedTech Acquisition Corporation (the “Company”) announced today that it closed its initial public offering of 25,000,000 units, which included 3,000,000...

2 years ago - GlobeNewsWire

MedTech Acquisition Corporation Announces Pricing of Upsized $220,000,000 Initial Public Offering

New York, NY, Dec. 17, 2020 (GLOBE NEWSWIRE) -- MedTech Acquisition Corporation (the “Company”) announced today that it priced its upsized initial public offering of 22,000,000 units at $10.00 per uni...

2 years ago - GlobeNewsWire